Outpace Bio

Outpace Bio is a Seattle-based biotechnology company revolutionizing cell therapy with their protein design expertise. They aim to cure solid tumors by developing technologies that overcome the barriers to efficacy and safety in cell therapy. Outpace uses AI-powered protein design to create proteins that program engineered cells for improved function inside patients, addressing issues like tumor suppression of the immune response, cell therapy persistence, and limited potency, safety, and specificity.

Outpace has a strong focus on internal development as well as strategic collaborations with leading industry players. Their internal pipeline includes a mesothelin-specific CAR T cell therapeutic candidate called OPB-101, which has shown promising results in preclinical models and is on track for IND submission in 2025. They have also formed partnerships with companies like Lyell Immunopharma and renowned researchers like David Baker and Stan Riddell to leverage their combined expertise and accelerate the development of their cell therapy platform.

Outpace Bio offers employees flexible work options, including the ability to work from home, as well as state-of-the-art lab and office space in Seattle's biotech hub. They also offer flexible paid time off and holiday pay, as well as excellent health and parental leave benefits.

Outpace Bio offers a comprehensive benefits package designed to support employee well-being and career growth. Employees enjoy flexible paid time off and holiday pay, excellent health and parental leave benefits, and flexible work options. The company also provides access to state-of-the-art lab and office space in Seattle's biotech hub, commuter benefits, and a robust package of additional benefits including stock options, 401(k), life insurance, long-term disability, and more.

Outpace Bio is a cell therapy company focused on curing solid tumors by revolutionizing cell therapy with protein design. The company uses AI-powered protein design to create proteins that program engineered cells for improved function inside patients, aiming to overcome the limitations of current cancer treatments and build a future where all cell therapies are effective and safe.

Outpace Bio cultivates a collaborative and inclusive culture built on respect, where employees are encouraged to bring their whole selves to work and are valued for their diverse backgrounds. The company prioritizes rigorous science and cross-functional collaboration to drive groundbreaking innovation in the field of cell therapy. These values are essential for creating a positive and supportive work environment where everyone is excited to contribute to Outpace's mission of curing disease.

Outpace Bio is committed to building an open, diverse, and inclusive culture for all employees, recognizing that high-performing teams include people from a wide variety of backgrounds. They believe that respect and inclusion are fundamental to collaboration and innovation, and encourage employees to bring their full selves to work. They are committed to creating an environment where everyone is excited to come to work each day, while encouraging excellence in everything that they do.